Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine and Training for Lower Limb Function in SCI
NCT02635893Phase 4Completed
- Sponsor
- Shirley Ryan AbilityLab
- Start
- Jun 2019
- Primary completion
- Mar 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in spinal cord injury (SCI), sponsored by Shirley Ryan AbilityLab. Started Jun 2019; status: completed.
02
Drugs
d-cycloserine
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02635893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02635893.